The underlying pathophysiology remains unclear; however, natriuretic peptides and NT-proBNP are likely to directly reflect the subclinical cardiac damage from silent myocardial ischemia, left ventricular hypertrophy, or increased apoptosis that impacts on CV mortality and is often associated with moderately reduced renal function [6]. This evidence concerns the gene NPPB and myocardial ischemia.